BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3188472)

  • 1. [Effect of hemosorption on the clinical course of chronic liver diseases].
    Kurdybaĭlo FV; Kolmakov VN; Nechaev IV; Potapova IV; Radchenko VG
    Vrach Delo; 1988 Jul; (7):60-3. PubMed ID: 3188472
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of hemosorption in the treatment of patients with chronic liver diseases].
    Radchenko VG; Litvinov AS; Vinogradova GL
    Ter Arkh; 1987; 59(2):118-21. PubMed ID: 3576464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of hemosorption on blood insulin levels in patients with chronic liver failure].
    Sitnikov VA; Pozdeev SR; Bryndin VV; Zelenin AA
    Vrach Delo; 1983 Aug; (8):91-4. PubMed ID: 6356596
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of hemosorption on collagen metabolic indices in chronic liver diseases].
    Sitnikov VA; Sharaev PN
    Vrach Delo; 1987 Sep; (9):37-40. PubMed ID: 3424770
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of determining erythrocyte membrane permeability in the diagnosis of chronic liver diseases].
    Kolmakov VN; Radchenko VG
    Ter Arkh; 1982; 54(2):59-62. PubMed ID: 7071775
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in using hemosorption in treating liver failure].
    Skiba VV; Voĭtenko GH; Kolesnikov EB; Zubkov VI; Bondarevskaia TM
    Klin Med (Mosk); 1980 Apr; 58(4):87-90. PubMed ID: 7382374
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemosorption in the correction of disorders of the transport function of erythrocytes in diseases of the respiratory organs].
    Ostapenko VA
    Vestn Khir Im I I Grek; 1989 Feb; 142(2):85-7. PubMed ID: 2728257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New technique and methods of combined hemosorption].
    Dubrovskií AK; Ivlev VA
    Khirurgiia (Mosk); 1997; (9):49-50. PubMed ID: 9499138
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevalence of the surface antigen of the hepatitis type B virus (HBsAg) in chronic hepatic disease].
    Ocaña Andrade E; Valverde Castañeda N; Garrido Palma J; Carrillo Cambero JL
    Rev Gastroenterol Mex; 1985; 50(1):19-22. PubMed ID: 4089439
    [No Abstract]   [Full Text] [Related]  

  • 10. [Permeability of erythrocyte membranes in patients with chronic liver diseases].
    Kadyvkina ZM; Kolmakov VN; Radchenko VG
    Klin Med (Mosk); 1987 Aug; 65(8):57-9. PubMed ID: 3682734
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of hemosorption on the blood levels of certain hormones in patients with pancreonecrosis and the hepatorenal syndrome].
    Riabov GA; Pospelov VV; Semenov VN; Bunin VM; Emtsov IuG
    Anesteziol Reanimatol; 1982; (3):35-7. PubMed ID: 7114564
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic HBsAg-negative liver disease. Presence of the markers of hepatitis B virus (HBV) infection and their possible meaning].
    Diodati G; Pontisso P; Pornaro E; Stenico D; Bonetti P; Realdi G; Ruol A
    Ann Ital Med Int; 1987; 2(3):195-200. PubMed ID: 3275282
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic liver disease in Afghanistan: contribution of hepatitis viruses.
    Lesser PB; Clement D; Dienstag JL; Bhan AK
    J Indian Med Assoc; 1983 Nov; 81(9-10):153-5. PubMed ID: 6674349
    [No Abstract]   [Full Text] [Related]  

  • 14. [Incidence of delta antibodies in patients with chronic HBsAg-positive liver diseases].
    Hadzić N; Candrlić I; Vucelić B; Juricić M; Dubravcić D
    Lijec Vjesn; 1986 Sep; 108(9):360-2. PubMed ID: 3453860
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tissue markers of hepatitis B virus: useful indicators in the etiologic diagnosis of chronic alcoholic and non-alcoholic liver disease].
    Cuccurullo L; Rambaldi M; Iaquinto G; Ferraraccio F; Ambrosone L; Giardullo N; De Vita A
    Recenti Prog Med; 1986 Sep; 77(9):397-400. PubMed ID: 3797789
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemosorption in the complex treatment of liver and biliary tract diseases].
    Dubrovskiĭ AK; Belov NN; Kondrashev VF
    Khirurgiia (Mosk); 1979 Apr; (4):69-73. PubMed ID: 459299
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBs and HBc antigens in the liver of patients with chronic liver diseases].
    Jabłońska-Kaszewska I; Bielawski W; Zółtowska A; Zamorska I; Fenc E
    Pol Tyg Lek; 1982 Jun; 37(19-20):541-4. PubMed ID: 7177943
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differential approach to hemodialysis, hemosorption and isolated ultrafiltration in acute kidney-liver failure].
    Bukin VE; Shifrin GA; Oleĭnik PP; Stupakov VI; Taslitskiĭ LI
    Anesteziol Reanimatol; 1985; (2):68-70. PubMed ID: 4003845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.